CLU rs9331888 Polymorphism Contributes to Alzheimer’s Disease Susceptibility in Caucasian But Not East Asian Populations

Molecular Neurobiology

Volumn 53, Issue 3, 2016, Pages 1446-1451

  Zhang, Shuyan ^a   Li, Xuling ^a   Ma, Guoda ^b   Jiang, Yongshuai ^a   Liao, Mingzhi ^c   Feng, Rennan ^a   Zhang, Liangcai ^d   Liu, Jiafeng ^e   Wang, Guangyu ^a   Zhao, Bin ^b   Jiang, Qinghua ^f   Li, Keshen ^b   Liu, Guiyou ^g  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

^c NORTHWEST A F UNIVERSITY   (China)

^d Rice University   (United States)

^e First Hospital of Harbin   (China)

^f HARBIN INSTITUTE OF TECHNOLOGY   (China)

^g Tianjin Airport Economic Area   (China)

Author keywords

Alzheimer s disease; Genome wide association studies (GWAS); Single nucleotide polymorphisms

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; CAUCASIAN; CLU GENE; DISEASE PREDISPOSITION; EAST ASIAN; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC DATABASE; GENETIC HETEROGENEITY; GENETIC MODEL; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; MOLECULAR PATHOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; ETHNOLOGY; GENETICS; META ANALYSIS; ODDS RATIO;

CLU PROTEIN, HUMAN; CLUSTERIN;

ALLELES; ALZHEIMER DISEASE; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CLUSTERIN; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84961134387     PISSN: 08937648     EISSN: 15591182     Source Type: Journal    
DOI: 10.1007/s12035-015-9098-1     Document Type: Article

References (31)

1. Liu G, Yao L, Liu J, Jiang Y, Ma G, Chen Z, Zhao B, Li K (2014) Cardiovascular disease contributes to Alzheimer’s disease: evidence from large-scale genome-wide association studies. Neurobiol Aging 35:786–792
2. Liu G, Wang H, Liu J, Li J, Li H, Ma G, Jiang Y, Chen Z et al (2014) The CLU gene rs11136000 variant is significantly associated with Alzheimer’s disease in caucasian and asian populations. Neuromolecular Med 16:52–60
3. Reitz C, Jun G, Naj A, Rajbhandary R, Vardarajan BN, Wang LS, Valladares O, Lin CF et al (2013) Variants in the ATP-binding cassette transporter (ABCA7), apolipoprotein E 4, and the risk of late-onset Alzheimer disease in African Americans. JAMA 309:1483–1492
4. Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, DeStafano AL, Bis JC et al (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat Genet 45:1452–1458
5. Miyashita A, Koike A, Jun G, Wang LS, Takahashi S, Matsubara E, Kawarabayashi T, Shoji M et al (2013) SORL1 is genetically associated with late-onset Alzheimer’s disease in Japanese, Koreans and Caucasians. PLoS One 8:e58618
6. Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C et al (2013) TREM2 variants in Alzheimer’s disease. N Engl J Med 368:117–127
7. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D et al (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease. Nat Genet 41:1094–1099
8. Chen LH, Kao PY, Fan YH, Ho DT, Chan CS, Yik PY, Ha JC, Chu LW et al (2012) Polymorphisms of CR1, CLU and PICALM confer susceptibility of Alzheimer’s disease in a southern Chinese population. Neurobiol Aging 33(210):e211–217
9. Yu JT, Li L, Zhu QX, Zhang Q, Zhang W, Wu ZC, Guan J, Tan L (2010) Implication of CLU gene polymorphisms in Chinese patients with Alzheimer’s disease. Clin Chim Acta 411:1516–1519
10. Lu SJ, Li HL, Sun YM, Liu ZJ, Yang P, Wu ZY (2014) Clusterin variants are not associated with southern Chinese patients with Alzheimer’s disease. Neurobiol Aging 35(2656):e2659–2611
11. Komatsu M, Shibata N, Kuerban B, Ohnuma T, Baba H, Arai H (2011) Genetic association between clusterin polymorphisms and Alzheimer’s disease in a Japanese population. Psychogeriatrics 11:14–18
12. Liu G, Li F, Zhang S, Jiang Y, Ma G, Shang H, Liu J, Feng R et al (2014) Analyzing large-scale samples confirms the association between the ABCA7 rs3764650 polymorphism and Alzheimer’s disease susceptibility. Mol Neurobiol 50(3):757–64. doi:10.1007/s12035-014-8670-4
13. Chen H, Wu G, Jiang Y, Feng R, Liao M, Zhang L, Ma G, Chen Z et al (2014) Analyzing 54,936 samples supports the association between CD2AP rs9349407 polymorphism and Alzheimer’s disease susceptibility. Neurobiol, Mol. doi:10.1007/s12035-014-8834-2
14. Liu G, Zhang S, Cai Z, Ma G, Zhang L, Jiang Y, Feng R, Liao M et al (2013) PICALM gene rs3851179 polymorphism contributes to Alzheimer’s disease in an Asian population. Neuromolecular Med 15:384–388
15. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560
16. Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634
17. Sterne JA, Egger M (2001) Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis. J Clin Epidemiol 54:1046–1055
18. Song F, Khan KS, Dinnes J, Sutton AJ (2002) Asymmetric funnel plots and publication bias in meta-analyses of diagnostic accuracy. Int J Epidemiol 31:88–95
19. Elias-Sonnenschein LS, Helisalmi S, Natunen T, Hall A, Paajanen T, Herukka SK, Laitinen M, Remes AM et al (2013) Genetic loci associated with Alzheimer’s disease and cerebrospinal fluid biomarkers in a Finnish case-control cohort. PLoS One 8:e59676
20. Braskie MN, Jahanshad N, Stein JL, Barysheva M, McMahon KL, de Zubicaray GI, Martin NG, Wright MJ et al (2011) Common Alzheimer’s disease risk variant within the CLU gene affects white matter microstructure in young adults. J Neurosci 31:6764–6770
21. Thambisetty M, Beason-Held LL, An Y, Kraut M, Nalls M, Hernandez DG, Singleton AB, Zonderman AB et al (2013) Alzheimer risk variant CLU and brain function during aging. Biol Psychiatry 73:399–405
22. Sweet RA, Seltman H, Emanuel JE, Lopez OL, Becker JT, Bis JC, Weamer EA, DeMichele-Sweet MA et al (2012) Effect of Alzheimer’s disease risk genes on trajectories of cognitive function in the cardiovascular health study. A J Psychiatry 169:954–962
23. Yu JT, Tan L (2012) The role of clusterin in Alzheimer’s disease: pathways, pathogenesis, and therapy. Mol Neurobiol 45:314–326
24. Xing YY, Yu JT, Cui WZ, Zhong XL, Wu ZC, Zhang Q, Tan L (2012) Blood clusterin levels, rs9331888 polymorphism, and the risk of Alzheimer’s disease. J Alzheimers Dis 29:515–519
25. Szymanski M, Wang R, Bassett SS, Avramopoulos D (2011) Alzheimer’s risk variants in the clusterin gene are associated with alternative splicing. Transl Psychiatry 1:e18
26. Erk S, Meyer-Lindenberg A, Opitz von Boberfeld C, Esslinger C, Schnell K, Kirsch P, Mattheisen M, Muhleisen TW et al (2011) Hippocampal function in healthy carriers of the CLU Alzheimer’s disease risk variant. J Neurosci 31:18180–18184
27. Thambisetty M, Beason-Held LL, An Y, Kraut M, Nalls M, Hernandez DG, Singleton AB, Zonderman AB et al (2013) Alzheimer risk variant CLU and brain function during aging. Biol Psychiatry 73:399–405
28. Allen M, Zou F, Chai HS, Younkin CS, Crook J, Pankratz VS, Carrasquillo MM, Rowley CN et al (2012) Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology 79:221–228
29. Daimon M, Oizumi T, Karasawa S, Kaino W, Takase K, Tada K, Jimbu Y, Wada K et al (2011) Association of the clusterin gene polymorphisms with type 2 diabetes mellitus. Metabolism 60:815–822
30. Zhang S, Zhang D, Jiang Y, Wu L, Shang H, Liu J, Feng R, Liao M et al (2014) CLU rs2279590 polymorphism contributes to Alzheimer’s disease susceptibility in Caucasian and Asian populations. J Neural Transm. doi:10.1007/s00702-014-1260-9
31. Naj AC, Jun G, Beecham GW, Wang LS, Vardarajan BN, Buros J, Gallins PJ, Buxbaum JD et al (2011) Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer’s disease. Nat Genet 43:436